DIPLOMAT PHARMACY INC's ticker is DPLO and the CUSIP is 25456K101. A total of 169 filers reported holding DIPLOMAT PHARMACY INC in Q2 2016. The put-call ratio across all filers is 0.40 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $32,000 | -50.8% | 8,070 | -38.9% | 0.00% | – |
| Q3 2019 | $65,000 | -15.6% | 13,210 | +3.9% | 0.00% | -100.0% |
| Q2 2019 | $77,000 | +7600.0% | 12,710 | +16846.7% | 0.00% | – |
| Q2 2018 | $1,000 | 0.0% | 75 | 0.0% | 0.00% | – |
| Q1 2018 | $1,000 | -83.3% | 75 | -71.2% | 0.00% | – |
| Q4 2017 | $6,000 | +200.0% | 260 | +246.7% | 0.00% | – |
| Q3 2017 | $2,000 | +100.0% | 75 | +36.4% | 0.00% | – |
| Q2 2017 | $1,000 | 0.0% | 55 | 0.0% | 0.00% | – |
| Q1 2017 | $1,000 | -85.7% | 55 | -77.8% | 0.00% | – |
| Q3 2016 | $7,000 | -86.8% | 248 | -84.2% | 0.00% | -100.0% |
| Q2 2016 | $53,000 | +152.4% | 1,565 | +106.2% | 0.00% | – |
| Q1 2016 | $21,000 | +5.0% | 759 | +31.3% | 0.00% | – |
| Q4 2015 | $20,000 | +300.0% | 578 | +210.8% | 0.00% | – |
| Q3 2015 | $5,000 | -37.5% | 186 | -38.0% | 0.00% | – |
| Q4 2014 | $8,000 | – | 300 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Empirical Capital Management, LLC | 479,018 | $9,298,000 | 8.38% |
| Rhenman & Partners Asset Management AB | 1,174,411 | $22,795,000 | 2.28% |
| Capital Investment Advisory Services, LLC | 153,842 | $2,986,000 | 1.40% |
| Cortina Asset Management, LLC | 1,238,420 | $24,038,000 | 1.12% |
| Investors Research Corp | 92,027 | $1,786,000 | 1.02% |
| Matarin Capital Management, LLC | 697,387 | $13,536,282,000 | 0.87% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 853,687 | $16,570,000 | 0.59% |
| RICE HALL JAMES & ASSOCIATES, LLC | 809,257 | $15,708,000 | 0.56% |
| BROADVIEW ADVISORS LLC | 156,700 | $3,042,000 | 0.52% |
| FRONTIER CAPITAL MANAGEMENT CO LLC | 3,535,217 | $68,619,000 | 0.44% |